SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

IsoRay, Inc. – ‘8-A12B’ on 4/12/07

On:  Thursday, 4/12/07, at 2:04pm ET   ·   Accession #:  1144204-7-18393   ·   File #:  1-33407

7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/12/07  IsoRay, Inc.                      8-A12B                 1:20K                                    Vintage/FA

Registration of a Class of Securities   —   Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B      Registration of a Class of Securities               HTML     16K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934


IsoRay, Inc.
(Exact name of registrant as specified in its charter)


Minnesota
 
41-1458152
(State of incorporation or organization)
 
(I.R.S. Employer Identification No.


350 Hills Street, Suite 106, Richland, Washington
 
99354
(Address of principal executive offices)
 
(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class To Be So Registered
   
Name of Each Exchange On Which
     
Each Class Is To Be Registered
Common Stock, $0.001 par value per share
   
American Stock Exchange

Securities to be registered pursuant to Section 12(g) of the Act:

None

If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o 

Securities Act registration statement file number to which this form relates:     N/A     (if applicable).
 
 
 

 

Item 1.
Description of Securities to be Registered

The description of the common stock of Registrant set forth under the caption “Description of Capital Stock” in Registrant’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission on January 26, 2007 (Registration No. 333-140246) (the “Registration Statement”), and in the prospectus included in the Registration Statement, is hereby incorporated by reference in response to this item.

Item 2. 
Exhibits

Because no other securities of the Registrant are registered on the American Stock Exchange, and the securities being registered by this Form 8-A are not registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, no exhibits are required to be filed with this Form 8-A.

 
 

 
 
Signature

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     
  ISORAY, INC.
 
 
 
 
 
 
Date: April 12, 2007    /s/ Roger E. Girard
 
 
Roger E. Girard
Chief Executive Officer

 
 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-A12B’ Filing    Date    Other Filings
Filed on:4/12/07
1/26/07S-3
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/09/24  Perspective Therapeutics, Inc.    424B3                  1:171K                                   RDG Filings/FA
 4/01/24  Perspective Therapeutics, Inc.    S-8         4/01/24    4:121K                                   RDG Filings/FA
 3/29/24  Perspective Therapeutics, Inc.    S-3                    4:280K                                   RDG Filings/FA
 1/18/24  Perspective Therapeutics, Inc.    424B5                  1:645K                                   RDG Filings/FA
 1/17/24  Perspective Therapeutics, Inc.    424B5                  1:648K                                   RDG Filings/FA
12/07/23  Perspective Therapeutics, Inc.    S-3/A                  3:524K                                   RDG Filings/FA
11/17/23  Perspective Therapeutics, Inc.    S-3                    7:1.4M                                   RDG Filings/FA
Top
Filing Submission 0001144204-07-018393   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 11:56:16.1am ET